Tylenol. Risperdal. Baby powder. Trusted brands. Huge lawsuits. And now the vaccine that may be mandated for you to access society soon... Johnson & Johnson has been tapped by the US Government to create a Coronavirus vaccine. Imaging the market - and no product liability.
From DRUGWATCH: Johnson & Johnson is the world’s largest health care company. It is also the highest paid drug company in the world. J&J remains at the top of the Big Pharma list of powerful corporations. It is well known for consumer products like Band-Aids, Johnson’s Baby Powder and Tylenol. Its drugs, devices and products have led to scandals and lawsuits. A Huffington Post investigation called J&J “America’s most admired lawbreaker.”
HUFFINGTON POST: Over the course of 20 years, Johnson & Johnson created a powerful drug, promoted it illegally to children and the elderly, covered up the side effects and made billions of dollars. This is the inside story.
And in current news:
The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson
The Trump administration is spending nearly half a billion dollars on one company in the race to find a coronavirus vaccine.
That’s according to a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen, which specified a “new vaccine asset for 2019 Novel Coronavirus (COVID-19),” Forbes found. It’s the largest reported amount spent on a vaccine project to date, even though the pharma giant hasn’t yet started any clinical trials as other firms have.
The deal was signed with the Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) on March 27, 2020. It followed another order, made as part of the same contract with Janssen, for $150 million on March 20, 2020, for a “new antiviral” for COVID-19.
A spokesperson from Johnson & Johnson didn’t provide any more details on the specific order, but confirmed the $456 million award related to a collaboration with ASPR’s Biomedical Advanced Research and Development Authority (BARDA), as announced in February. That work was built on previous contracts for developing countermeasures for other influenzas. The value of the coronavirus-specific work hadn’t previously been revealed and is the largest known contract for a coronavirus vaccine to date.